Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 1997

View Archived Issues

Human SMC migration factor and modulators thereof described by SKB and HGS

GnRH conjugate vaccines prepared at Merck & Co.

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

Chiroscience reports PDE/TNF inhibitors

Trovafloxacin extensively covered at recent congress

Efficacy reported for FR-167653 in animal model of septic shock

Nasal vs. rectal midazolam as premedication in children

New emulsion formulation of tacrolimus provides local immunosuppression

JTV-506 shows potential for asthma

Prosorba column trial for rheumatoid arthritis to continue

New protease inhibitor from HMR characterized

Cypros licenses patents for CPC-111 in organ transplant

SAR described for small-molecule ETA antagonists from ImmunoPharmaceutics

FDA approves Niaspan for the treatment of mixed lipid disorders

Research Triangle Institute investigates compounds for male fertility control

Potent and selective AMPA antagonist discovered by Yamanouchi

Device for snoring cleared by FDA

FDA to regulate ultrasound contrast agents as drugs

FDA advisory panel recommends nonapproval of Heart Laser TMR System

Molecular Biosystems' Optison reclassified as drug

New Japanese distribution agreement for Cortecs' H. pylori test

Licenses offered for cell replication technology

Daiichi's new anticancer agent enters overseas clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...